Article
Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.
Pathology, research and practice - 1 Sept 2020
Krishnamurthy Kritika, Cusnir Mike, Schwartz Michael, Sriganeshan Vathany, Poppiti Robert J
Abstract excerpt
BACKGROUND: Neuroendocrine carcinomas (NECs) arise from neuroendocrine cells present throughout the body, and often present with metastases even with small and undetectable primary tumors. Additionally, neuroendocrine differentiation can be seen in carcinomas of non-neuroendocrine origin further complicating the landscape of metastatic NECs. Organ specific immunohistochemical markers such as TTF1, CDX2 and PAX8...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.